By Hiroshi Sheraton and Matthew Jones, McDermott Will & Emery
A European Patent currently consists of a bundle of national patent rights that must be enforced separately in each signatory state to the European Patent Convention. Longstanding intentions to create a single, unitary patent right across Europe and to provide a single court in which to litigate European patents have recently taken a step forward. This article reviews the latest draft proposal for a Unified Patent Court made by the EU Council Presidency and discusses its effect.
Turning back to proposals for a harmonised litigation process, these too have met with judicial obstacles in the past.
A first modern attempt to provide a single European patent court was under discussion since 1999. This proposal, known as the European Patent Litigation Agreement ("EPLA"), was supported by a powerful group of patent judges from different European national jurisdictions, and many of its mechanisms have been adopted in subsequent proposals. However, the EPLA would apply only to European Patents as a protocol to the European Patent Convention, and would therefore be entirely separate from the Single Community Patent. In January 2007, the legal division of the European Parliament gave its opinion that the EPLA would be unlawful as a matter of European Community law as it violated the EU's exclusive jurisdiction governing such matters.
In 2009, a further draft agreement on a European and EU Patents Court ("EEUPC") was proposed1 whose jurisdiction would include both European Patents and unified Community Patents. That agreement proposed the establishment of a single court, with regional divisions, a central division and a single court of appeal. The Court would stand alongside national courts, but it would have exclusive jurisdiction on patent matters. Moreover, the Court would be expressly subject to European Community law and answerable to the CJEU. However, in March 2011 (in fact, around the time the European Council approved enhanced cooperation with respect to the unitary patent), the CJEU ruled that the proposed agreement would be unconstitutional2 at least insofar as it related to unitary patent rights. In particular, this was because the agreement would deprive courts of Member States of their powers in relation to the interpretation and application of European Union law, and thereby deprive the CJEU of its powers to reply to questions referred by those courts.3 Other problems identified were the lack of accountability of the signatory member states and the inclusion of non-EU signatories (such as Switzerland).
Since March 2011, the Commission has therefore been considering how best to revise and implement a unified patent litigation system in Europe in light of the CJEU's opinion. Those considerations led to publication of the Commission's 'non-paper' on "solutions for a united patent litigation system,"4 which was presented in advance of the meetings of the Competitiveness Council on 30-31 May 2011. Now, the EU Council Presidency has published the present draft agreement on a Unified Patent Court.
The Court would comprise a Court of First Instance ("CFI"), a Court of Appeal, and a registry.5 The CFI would itself be divided into central, local, and regional divisions.6 At present, it is not known where either the central division of the CFI or the Court of Appeal would be located.7
It is envisaged that any panel of the CFI will have a multinational composition of three judges.8 Judges would be divided into legally and technically qualified: panels of the local or regional divisions of the CFI would be able to request (where appropriate and having heard the parties) allocation of one technically qualified judge to the panel,9 while panels of the central division would always comprise two legally qualified judges and one technically qualified judge.10 All panels of the CFI would be chaired by a legally qualified judge.11
A panel of the Court of Appeal would have a multinational composition of five judges, of which three would be legally qualified judges and two would be technically qualified,12 and would be chaired by a legally qualified judge.13
The Court would have exclusive jurisdiction with respect to actions for infringement, declarations of non-infringement, injunctions, revocation, compensation relating to published applications, prior use rights, and actions relating to compensation for licences and decisions of the European Patent Office on the basis of specific articles of the Regulation implementing the enhanced cooperation for the unitary patent.15
Actions for infringement, injunctions, compensation relating to published applications, and prior use rights would be brought before the local division or regional division based upon either the domicile of the defendant or the place where the infringement occurred or might occur. If the relevant contracting Member State does not host a local division or participate in a regional division, such actions would be brought before the central division.16
Other actions (including chiefly actions for revocation and for declarations of non-infringement) would be brought before the central division, but could only be initiated if no action for infringement had been initiated between the same parties and relating to the same patent before a local or regional division.17 If a counterclaim for revocation is brought in an infringement action before a local or regional division, that division has discretion (having heard the parties) to either proceed with both the action and counterclaim and request allocation of a technically qualified judge to its panel, refer the counterclaim alone to the central division, or refer the whole case (i.e. including the infringement action) to the central division.18 However, the parties also have the right to agree to bring any action before a division of their choice, including the central division.19
These provisions accommodate the two fundamentally different systems for patent litigation that currently exist in Europe, i.e. the bifurcated system wherein infringement and revocation are decided by different courts (such as exists in Germany) and the system wherein infringement and revocation are decided in the same court (such as exists in the vast majority of other EU Member States). At its core, the envisaged system provides that a validity action will be heard by a panel comprising a technically qualified judge, while allowing some freedom for local and regional divisions to deal with other types of action (such as a "pure" infringement action) independently. However, where both infringement and revocation are in issue (which in practice is typically the case) the draft agreement allows flexibility regarding whether or not the cases are heard together and in which division they are heard. It remains to be seen how the different divisions of the Court will apply their discretion in practice.
In the central division, the language of the proceedings is the language in which the patent was granted.23
In the Court of Appeal, the language of proceedings is the same as that before the CFI,24 unless the parties agree on the use of the language in which the patent was granted.25
The draft agreement states explicitly, in an unqualified stand-alone provision, that the Court shall apply the entire body of EU law and respect its primacy.27Further, it specifies that the Court shall cooperate with the CJEU to ensure the proper application and uniform interpretation of EU law in the same way as the national courts of EU Member States.28 In particular, the Court should request preliminary rulings from the CJEU on the interpretation of the Treaties or the validity and interpretation of acts of the institutions, bodies, offices, or agencies of the EU in accordance with Article 267 TFEU, in the same manner as national courts,29 and such rulings would be binding upon the Court.30 Further, the contracting Member States would be jointly and severally liable for damages incurred by parties before the Court of Appeal and arising from breach of EU law by the Court of Appeal.31
All of these provisions are aimed squarely at addressing the CJEU's concerns as expressed in their opinion on the EEUPC and are clearly intended to address the CJEU's opinion directly.
The first is the potential incompatibility of the proposed agreement with the Brussels I Regulation,32 which provides (inter alia) that the courts of each Member State shall have exclusive jurisdiction in proceedings concerning the validity of any European patent granted for that state.33 As such, in order to proceed with the agreement in the form currently drafted, at least that particular EU regulation will need to be amended. The complex mechanisms for amending Regulations mean that political objections from countries such as Spain or Italy may threaten adoption of the agreement in the short term.
In addition, the compatibility of the proposal with EU law and national constitutional laws has not been tested. The CJEU's opinion in relation to the EEUPC was somewhat unexpected, and it would not be surprising if a further opinion is sought in relation to the draft agreement, which would introduce further delay and uncertainty.
It must also be borne in mind that the CJEU did not previously address any question of compatibility in relation to a system for litigating existing European Patents granted under the EPC. Whether the current proposal is sufficient to address residual concerns following the European Parliament's rejection of the EPLA (see above) also remains to be seen.
Hiroshi Sheraton is a partner in the international firm of McDermott Will & Emery, based in the London office. His practice focuses on IP litigation and he has particular experience in conducting and co-ordinating disputes internationally, especially within Europe. Most of his cases have an international dimension and he has co-ordinated cases with up to 10 different jurisdictions relating to the same patent.
Matthew Jones is an associate in the law firm of McDermott Will & Emery UK LLP, based in its London office. He focuses his practice on patent litigation and non-contentious intellectual property matters. Matthew has a degree and PhD in biochemistry. Matthew has advised on a number of UK and international disputes relating to patent infringement and validity, involving a wide range of technologies across the IT/telecoms and pharmaceutical/biotechnology sectors. He also has experience of EPO patent opposition proceedings. He has also advised on provisions of general commercial agreements, including confidentiality agreements, materials transfer agreements and patent license agreements.
©2014 The Bureau of National Affairs, Inc. All rights reserved. Bloomberg Law Reports ® is a registered trademark and service mark of The Bureau of National Affairs, Inc.
To view additional stories from Bloomberg Law® request a demo now